Related Experiment Video
Updated: Jun 24, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Implementing absolute cardiovascular disease risk assessment into pathology collection services
Lisa Pagano1, James E Sharman2, Rose Nash3
1Australian Institute of Health Innovation, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
Integrating cardiovascular disease (CVD) risk estimation into pathology services requires understanding site-specific factors and tailoring implementation strategies. This approach informs future service integration and sustainability for better patient outcomes.
Area of Science:
- Public Health
- Health Services Research
- Preventive Cardiology
Background:
- Pathology services offer a prime setting for integrating cardiovascular disease (CVD) risk estimation during routine cholesterol testing.
- This study explored the implementation process of CVD risk estimation within point-of-care pathology services.
Purpose of the Study:
- To investigate the factors influencing the integration of CVD risk estimation into pathology service delivery.
- To inform future implementation and sustainability of such services.
Main Methods:
- A CVD risk estimation service was implemented across 14 pathology sites in Tasmania, Australia.
- Pre-implementation observations and staff interviews identified potential barriers and facilitators.
- Thematic analysis and a programme logic model were used to evaluate the implementation process.
Main Results:
- Eight key themes emerged, including organizational factors (resources, workflow, time), staff motivation, leadership, and patient characteristics.
- Implementation success varied across sites, necessitating adaptive strategies for service uptake and patient recruitment.
Conclusions:
- Successful integration of CVD risk estimation requires context-specific understanding and targeted implementation strategies.
- A generated programme logic model can guide future implementation efforts and strategy selection in pathology services.
More Related Videos
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pre-Procedural Guidelines for Assessing Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

